<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Acute bronchitis in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Acute bronchitis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Acute bronchitis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas M File, Jr, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Aronson, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheila Bond, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 11, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acute bronchitis is a common clinical condition characterized by an acute onset but persistent cough, with or without sputum production. It is typically self-limited, resolving within one to three weeks. Symptoms result from inflammation of the lower respiratory tract and are most frequently due to viral infection.</p><p>Treatment is focused on patient education and supportive care. Antibiotics are not needed for the great majority of patients with acute bronchitis but are greatly overused for this condition. Reducing antibiotic use for acute bronchitis is a national and international health care priority. (See <a class="local">'Avoiding antibiotic overuse'</a> below.)</p><p>The clinical features, diagnosis, and management of acute bronchitis are addressed here. Chronic bronchitis, a subtype of chronic obstructive pulmonary disease, is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7019.html" rel="external">"Management of infection in exacerbations of chronic obstructive pulmonary disease"</a> and  <a class="medical medical_review" href="/z/d/html/1455.html" rel="external">"Chronic obstructive pulmonary disease: Diagnosis and staging"</a>.)</p><p class="headingAnchor" id="H3245585097"><span class="h1">DEFINITIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Acute bronchitis is a lower respiratory tract infection involving the large airways (bronchi), without evidence of pneumonia, that occurs in the absence of chronic obstructive pulmonary disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic bronchitis is commonly seen in current and former smokers and is defined as a cough that lasts for at least three months in each of two successive years. (See  <a class="medical medical_review" href="/z/d/html/1455.html" rel="external">"Chronic obstructive pulmonary disease: Diagnosis and staging", section on 'Definitions'</a>.)</p><p></p><p class="headingAnchor" id="H2989892354"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Acute bronchitis is one of the most common conditions encountered in clinical practice. It accounts for approximately 10 percent of ambulatory care visits in the United States [<a href="#rid1">1</a>]. In the northern hemisphere, the incidence of acute bronchitis is highest in late fall and winter when transmission of respiratory viruses peaks  (<a class="graphic graphic_figure graphicRef139455" href="/z/d/graphic/139455.html" rel="external">figure 1</a>) [<a href="#rid2">2-4</a>].</p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H3"><span class="h2">Viruses</span><span class="headingEndMark"> — </span>Viruses are the most commonly identified pathogens in patients with acute bronchitis [<a href="#rid5">5-9</a>]. In two case series, viruses accounted for about 60 percent of cases in which pathogens were identified [<a href="#rid6">6,9</a>]. The most common viral causes of acute bronchitis include [<a href="#rid5">5,6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Influenza A and B</p><p class="bulletIndent1"><span class="glyph">●</span>Parainfluenza</p><p class="bulletIndent1"><span class="glyph">●</span>Coronavirus types 1 to 3</p><p class="bulletIndent1"><span class="glyph">●</span>Rhinoviruses</p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory syncytial virus</p><p class="bulletIndent1"><span class="glyph">●</span>Human metapneumovirus</p><p class="bulletIndent1"><span class="glyph">●</span>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19)</p><p></p><p>Of the viral agents that cause acute bronchitis, influenza and SARS-CoV-2 merit special consideration because of their morbidity and the potential for specific therapy. (See  <a class="medical medical_review" href="/z/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">"COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Other pathogens</span><span class="headingEndMark"> — </span>Bacteria are uncommon causes of acute bronchitis, accounting for only 6 percent of cases in a single series evaluating adults hospitalized with acute bronchitis [<a href="#rid6">6</a>]. The bacteria most commonly associated with acute bronchitis include <em>Bordetella pertussis</em>,<em> Mycoplasma pneumoniae</em>,<em> </em>and <em>Chlamydia pneumoniae </em>[<a href="#rid6">6,9,10</a>].</p><p>Among these bacteria, <em>B. pertussis </em>is the most likely to cause prolonged cough. The overall incidence of pertussis and associated outbreaks are rising worldwide [<a href="#rid11">11</a>]. In patients with prolonged cough, reported rates of pertussis range from 1 to 12 percent [<a href="#rid12">12,13</a>]. Pertussis is one of the few bacterial causes of acute bronchitis that may respond to antibiotic therapy.</p><p><em>M. pneumoniae</em> and <em>C. pneumoniae</em> are each common causes of upper respiratory tract infections. While each has the potential to cause lower respiratory tract infection, including both acute bronchitis and pneumonia, rates of prolonged cough or acute bronchitis caused by these bacteria vary among cases series, ranging from 0 to 6 percent [<a href="#rid6">6,14,15</a>].</p><p><em>Bordetella bronchiseptica</em>, the cause of kennel cough in dogs, is a rarely reported but likely under-recognized cause of cough in humans [<a href="#rid16">16,17</a>]. Clinical manifestations range from mild respiratory illnesses, such as bronchitis or pertussis-like syndromes, to pneumonia and sepsis [<a href="#rid16">16,18</a>]. Most infections occur in immunocompromised individuals exposed to farms or pets, although infections in immunocompetent patients and hospital-acquired transmission have been reported [<a href="#rid16">16,17,19-25</a>].</p><p>There is no convincing evidence to support the concept of "acute bacterial bronchitis," caused by pathogens such as <em>Streptococcus pneumoniae</em>, <em>Staphylococcus aureus</em>, <em>Haemophilus influenzae</em>, <em>Moraxella catarrhalis</em>, or other gram-negative bacilli in adults without airway instrumentation (eg, tracheostomy, endotracheal intubation) or chronic obstructive pulmonary disease. (See  <a class="medical medical_review" href="/z/d/html/7019.html" rel="external">"Management of infection in exacerbations of chronic obstructive pulmonary disease"</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Cough is the cardinal symptom of acute bronchitis. In most patients, the cough lasts for one to three weeks, with a median duration of 18 days [<a href="#rid3">3,12,26</a>]. The cough may be associated with either purulent or nonpurulent sputum production [<a href="#rid3">3,27</a>]. The presence of purulent sputum is a nonspecific finding and does not appear to be predictive of bacterial infection or response to antibiotics [<a href="#rid28">28,29</a>].</p><p>Upper respiratory tract infection (URI; eg, common cold) can precede the onset of acute bronchitis. Initially, symptoms associated with both conditions (eg, headache, nasal congestion, sore throat) may be present [<a href="#rid3">3,27</a>]. For some patients, URI symptoms resolve; for others, infection progresses to involve the lower tract (ie, acute bronchitis). With involvement of the lower respiratory tract, cough becomes the main feature. The frequency with which URIs progress to acute bronchitis is not known. </p><p>Wheezing and mild dyspnea may accompany the cough. Both wheezing and rhonchi may be auscultated on physical examination; rhonchi usually clear with coughing. Although pulmonary function testing is typically not indicated in clinical practice, bronchospasm, evidenced by reduced forced expiratory volume in one second (FEV<sub>1</sub>), has been reported in 40 percent of patients in a small case series [<a href="#rid30">30</a>], and bronchial hyperreactivity can be demonstrated with provocative testing [<a href="#rid7">7</a>]. Bronchial hyper-responsiveness is typically transient, resolving in six weeks, and is believed to be the mechanism that underlies the persistent cough [<a href="#rid7">7,30</a>].</p><p>With prolonged coughing, chest wall or substernal musculoskeletal pain can occur [<a href="#rid3">3,27</a>]. Other complications are rare; most common among them are the development of pneumonia or bacterial superinfection. For most patients, acute bronchitis is a self-limited illness that does not require specific diagnostic testing or treatment.</p><p>Certain clinical features suggest a specific cause or an alternate diagnosis  (<a class="graphic graphic_table graphicRef114182" href="/z/d/graphic/114182.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef113721" href="/z/d/graphic/113721.html" rel="external">table 2</a>). For example, paroxysms of cough accompanied by an inspiratory whoop or post-tussive emesis suggest pertussis (particularly during known outbreaks). Fever and other systemic symptoms are rare in patients with acute bronchitis. These findings, in addition to cough and sputum production, should raise suspicion for influenza or pneumonia  (<a class="graphic graphic_figure graphicRef135143" href="/z/d/graphic/135143.html" rel="external">figure 2</a>). On physical examination, signs of parenchymal consolidation (ie, dullness to percussion, decreased or bronchial breath sounds, rales, egophony, or signs of pleural inflammation such as a pleural rub) suggest that disease extends beyond the bronchi, and chest imaging should be considered. (See <a class="local">'Chest radiograph'</a> below.)</p><p class="headingAnchor" id="H15"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H1966994717"><span class="h2">Clinical diagnosis</span><span class="headingEndMark"> — </span>Acute bronchitis should be suspected in patients with an acute onset but persistent cough (often lasting one to three weeks) who do not have clinical findings suggestive of pneumonia (eg, fever, tachypnea, rales, signs of parenchymal consolidation) and do not have chronic obstructive pulmonary disease. For most patients, the diagnosis can be made based upon the history and physical examination. Testing for COVID-19 is recommended for all patients with prolonged cough. Otherwise, testing is generally reserved for cases in which pneumonia is suspected, the clinical diagnosis is uncertain, or when results would change management (eg, a positive influenza test result in a patient who meets criteria for antiviral therapy)  (<a class="graphic graphic_algorithm graphicRef131527" href="/z/d/graphic/131527.html" rel="external">algorithm 1</a>). <span class="utd-adt-cnt utd-adt-pathwys utd-content-120412">(Related Pathway(s):  <a class="utd-content-120412" href="/pathway/120412?topicRef=6870&amp;source=see_link">Acute bronchitis: Evaluation of suspected acute bronchitis in adults</a>.)</span></p><p class="headingAnchor" id="H16"><span class="h2">Chest radiograph</span><span class="headingEndMark"> — </span>Chest radiographs are unlikely to change management for most patients with acute cough [<a href="#rid31">31,32</a>]. In patients with acute bronchitis, chest radiographs are either normal or findings are nonspecific, though subtle changes consistent with thickening of the bronchial walls in the lower lobes are occasionally reported [<a href="#rid31">31</a>].</p><p>The primary reason for obtaining a chest radiograph is to exclude pneumonia  (<a class="graphic graphic_figure graphicRef135143" href="/z/d/graphic/135143.html" rel="external">figure 2</a>); reasonable indications for suspecting pneumonia and obtaining imaging include the following [<a href="#rid33">33-39</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal vital signs (pulse &gt;100/minute, respiratory rate &gt;22 breaths/minute, temperature &gt;38°C [100.4°F], or oxygen saturation &lt;95 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Signs of consolidation on chest examination (rales, egophony, or tactile fremitus)</p><p class="bulletIndent1"><span class="glyph">●</span>Mental status or behavioral changes in patients &gt;75 years old, who may not mount a fever</p><p></p><p>Additional factors, such as moderate or severe dyspnea, hemoptysis, immunocompromise, older age, and/or dementia, raise the likelihood of pneumonia or other underlying pulmonary disorders. The decision to obtain a chest radiograph or other imaging should always take the full clinical picture into consideration.</p><p class="headingAnchor" id="H17"><span class="h2">Microbiologic testing</span><span class="headingEndMark"> — </span>For most patients, testing for specific pathogens is not needed because results will not change management. Gram stain and bacterial cultures of expectorated sputum are specifically not recommended because bacterial pathogens are rare causes of acute bronchitis [<a href="#rid33">33,40-43</a>].</p><p>Circumstances in which microbiologic testing may change treatment options include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspicion for COVID-19</strong> – Testing for COVID-19 should be performed in all patients presenting with possible respiratory tract infections. (See  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspicion for influenza</strong> – Testing for influenza may be indicated in patients who are at high risk for complications  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 3</a>), hospitalized patients, and health care workers who may benefit from treatment and/or when results would be helpful for providing local surveillance data or implementing infection control measures. Testing options vary with clinical setting. When indicated, treatment should not be withheld while awaiting the results of diagnostic testing. (See  <a class="medical medical_review" href="/z/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspicion for pertussis</strong> – Microbiologic confirmation is usually not needed for patients with pertussis. When confirmation is desired based on patient risk status or public health concern, multiple testing options are available  (<a class="graphic graphic_figure graphicRef83305" href="/z/d/graphic/83305.html" rel="external">figure 3</a>). Selection of the most appropriate test varies by duration of cough. (See  <a class="medical medical_review" href="/z/d/html/8045.html" rel="external">"Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis", section on 'Approach to diagnosis'</a>.)</p><p></p><p>It is usually unrealistic and unnecessary to attempt to determine if <em>Mycoplasma</em> or <em>Chlamydia</em> are the etiologic agents of acute bronchitis. Diagnostic testing may be justified in suspected outbreaks, when antibiotics might limit spread [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/z/d/html/6989.html" rel="external">"<i>Mycoplasma pneumoniae</i> infection in adults", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/7036.html" rel="external">"Pneumonia caused by <i>Chlamydia pneumoniae</i> in adults", section on 'Diagnosis'</a>.)</p><p>Testing for <em>Bordetella </em>bronchiseptica, a rare cause of prolonged cough, may be warranted in patients with exposures to sick animals, such as veterinary workers, or in immunocompromised patients with respiratory illnesses that cannot be otherwise diagnosed. Culture of the organism from the affected site is the gold standard for diagnosis. Use of specialized transport and culture media is preferred when testing for <em>B. bronchiseptica</em>,<em> </em>and laboratories should be informed in advance when this organism is suspected [<a href="#rid16">16</a>]. Some polymerase chain reaction (PCR) assays designed for the detection of <em>Bordetella pertussis</em> also detect <em>B. bronchiseptica </em>[<a href="#rid45">45,46</a>]<em>.</em></p><p class="headingAnchor" id="H18"><span class="h2">Procalcitonin</span><span class="headingEndMark"> — </span>Procalcitonin is a serum biomarker that helps distinguish bacterial infection from other causes of infection or inflammation. We do not routinely use procalcitonin in the evaluation of patients with a clinical diagnosis of bronchitis. We reserve procalcitonin testing for cases in which there is diagnostic uncertainty and need for antibiotics is unclear. Testing should only be performed at centers where results can be obtained in a timely manner. (See  <a class="medical medical_review" href="/z/d/html/114753.html" rel="external">"Procalcitonin use in lower respiratory tract infections", section on 'Acute bronchitis'</a>.)</p><p class="headingAnchor" id="H14751396"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Because the diagnosis of acute bronchitis is clinical, it is important to assess for other causes of acute cough that may be reversible or require additional testing. The most common causes of acute cough are listed below and summarized in the table  (<a class="graphic graphic_table graphicRef113721" href="/z/d/graphic/113721.html" rel="external">table 2</a>) [<a href="#rid47">47</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pneumonia</strong> – Cough accompanied by abnormal vital signs (fever, tachypnea, or tachycardia), signs of consolidation or rales on physical examination, or mental status changes in older adult patients each suggest the possibility of pneumonia. In such cases, a confirmatory chest radiograph is needed to distinguish acute bronchitis from pneumonia  (<a class="graphic graphic_figure graphicRef135143" href="/z/d/graphic/135143.html" rel="external">figure 2</a>) [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/z/d/html/7032.html" rel="external">"Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>COVID-19</strong> – COVID-19 can present as an acute upper or lower respiratory tract infection. Cough and other symptoms such as dyspnea and fatigue can persist for prolonged periods following acute infection. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">"COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postnasal drip syndrome</strong> – The sensation of postnasal drainage, the need to frequently clear their throat, and/or rhinorrhea are consistent with postnasal drip. Postnasal drip can be caused by the common cold, allergic rhinitis, vasomotor rhinitis, postinfectious rhinitis, rhinosinusitis, and/or environmental irritants. (See  <a class="medical medical_review" href="/z/d/html/7533.html" rel="external">"An overview of rhinitis"</a> and  <a class="medical medical_review" href="/z/d/html/6871.html" rel="external">"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastroesophageal reflux (GERD)</strong> – Heartburn, regurgitation, and dysphagia are common symptoms of GERD, although cough may be the sole presenting symptom in some patients. (See  <a class="medical medical_review" href="/z/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asthma</strong> – A history of episodic wheezing, cough, and shortness of breath suggest asthma, particularly when these symptoms occur in response to triggers such as allergen or irritant exposure, exercise, or viral infections.</p><p></p><p class="bulletIndent1">For patients presenting with their first episode of asthma, it may not be possible to distinguish this diagnosis from acute bronchitis [<a href="#rid48">48</a>]. In one study, 65 percent of patients who had two or more episodes of bronchitis over a five-year period were found to have mild asthma [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/z/d/html/543.html" rel="external">"Asthma in adolescents and adults: Evaluation and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/536.html" rel="external">"Irritant-induced asthma"</a>.)</p><p></p><p class="bulletIndent1">For patients with known asthma, checking a peak flow expiratory rate can help determine whether an asthma exacerbation is complicating acute bronchitis and what additional treatment may be needed. (See  <a class="medical medical_review" href="/z/d/html/528.html" rel="external">"Acute exacerbations of asthma in adults: Home and office management", section on 'Detecting an exacerbation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ACE inhibitor use</strong> – A nonproductive cough is a well-recognized complication of treatment with angiotensin-converting enzyme (ACE) inhibitors, occurring in up to 15 percent of patients treated with these agents. For most, ACE inhibitor-induced cough arises within one week of starting therapy and presents as a tickling or scratchy sensation in the throat. It typically resolves within one to four days of discontinuing therapy but can take up to four weeks. (See  <a class="medical medical_review" href="/z/d/html/1460.html" rel="external">"Causes and epidemiology of subacute and chronic cough in adults", section on 'ACE inhibitors and other medications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Heart failure</strong> – Cough accompanied by shortness of breath, particularly with exertion or when lying flat, should raise suspicion for heart failure. Physical examination findings such as a gallop rhythm, displaced apical impulse, elevated jugular venous pressure, and peripheral edema should further heighten suspicion and indicate need for further testing. (See  <a class="medical medical_review" href="/z/d/html/3510.html" rel="external">"Heart failure: Clinical manifestations and diagnosis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary embolism (PE)</strong> – Dyspnea, pleuritic chest pain, and hemoptysis in addition to cough are classic symptoms associated with PE. However, presenting symptoms vary and can be mild and nonspecific. Physical examination findings also vary, but those that support this diagnosis include tachypnea, tachycardia, and lower extremity swelling. Any suspicion for PE warrants further evaluation. (See  <a class="medical medical_review" href="/z/d/html/8261.html" rel="external">"Clinical presentation, evaluation, and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lung cancer</strong> – Lung cancer is an uncommon cause of acute cough but should be considered in any current or prior smoker. Features that should raise suspicion for this diagnosis include a recent change in a chronic "smoker's cough," hemoptysis, and signs of focal airway obstruction on physical examination such as wheeze or decreased breath sounds.</p><p></p><p>Additional causes of prolonged cough and an approach to evaluation of patients with cough lasting &gt;3 weeks are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1460.html" rel="external">"Causes and epidemiology of subacute and chronic cough in adults"</a>.)</p><p>The differential diagnosis of prolonged cough in immunocompromised patients is more inclusive and discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1402.html" rel="external">"Epidemiology of pulmonary infections in immunocompromised patients"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>For most patients with acute bronchitis, symptoms are self-limited, resolving in about one to three weeks. Reassurance and symptom control are the cornerstones of care. Antibiotics are not recommended for routine use [<a href="#rid1">1,50-52</a>]. By definition, acute bronchitis occurs in the absence of chronic obstructive pulmonary disease (COPD). Symptoms of acute bronchitis that occur in patients with COPD typically indicate an acute exacerbation of COPD, which is managed differently. (See  <a class="medical medical_review" href="/z/d/html/1461.html" rel="external">"COPD exacerbations: Management"</a>.)</p><p class="headingAnchor" id="H1532377120"><span class="h2">Patient education</span><span class="headingEndMark"> — </span>We suggest having a discussion on the expected course of illness and treatment plan with all patients. Reassuring patients that acute bronchitis is a self-limited illness that typically resolves in one to three weeks without specific therapy can help improve patient satisfaction and reduce inappropriate antibiotic use [<a href="#rid3">3,27</a>].</p><p>For patients who request antibiotics, we encourage having an explicit discussion on the risks and benefits of their use (see <a class="local">'Avoiding antibiotic overuse'</a> below). For the great majority of patients, use of antibiotics does not hasten recovery or prevent complications but puts patients at increased risk of adverse effects including potentially severe complications such as <em>Clostridioides</em> <em>difficile</em> infection and anaphylaxis [<a href="#rid52">52,53</a>]. Provision of patient handouts, offering nonantibiotic medications for symptom control, engaging in shared decision-making [<a href="#rid54">54,55</a>], and using delayed prescriptions (eg, providing a prescription to be filled only if symptoms persist) can also help reduce antibiotic use; each has shown to be effective in randomized trials or meta-analyses [<a href="#rid56">56-62</a>]. (See <a class="local">'Information for patients'</a> below.)</p><p>The United States Centers for Disease Control and Prevention (CDC) handout for patients on the treatment and prevention of acute bronchitis can be found <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fantibiotic-use%2Fpdfs%2FPreventing-and-Treating-Bronchitis-H.pdf&amp;token=fpSNCSmxhK00gn5uiX2Ewize5sX%2FUPH%2Fd3WC7wcsk7kSyg3ynhXhMHp1MjEZShPkF6v1HnrpWE%2FrJdH6V7%2FhOQ5K2ybvi9hHrqgaeLCZnqCvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=6870" target="_blank">here</a>.</p><p class="headingAnchor" id="H2770958769"><span class="h2">Symptom control</span></p><p class="headingAnchor" id="H1519125071"><span class="h3">For cough</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonpharmacologic therapy</strong> – For patients with acute bronchitis who are bothered by cough, offering nonpharmacologic options for cough relief such as throat lozenges, hot tea, honey, and/or smoking cessation or avoidance of secondhand smoke is a reasonable first step. Most of these interventions have not been directly evaluated in clinical trials, however, they may provide some benefit and expected harms are small  (<a class="graphic graphic_table graphicRef138544" href="/z/d/graphic/138544.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/z/d/html/1428.html" rel="external">"Evaluation and treatment of subacute and chronic cough in adults", section on 'Nonpharmacologic interventions'</a> and  <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">"Overview of smoking cessation management in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pharmacologic therapy</strong> – For patients with acute bronchitis who desire medication for cough relief, we suggest offering over-the-counter (OTC) medications, such as <a class="drug drug_general" data-topicid="8893" href="/z/d/drug information/8893.html" rel="external">dextromethorphan</a> or <a class="drug drug_general" data-topicid="8503" href="/z/d/drug information/8503.html" rel="external">guaifenesin</a>. Selection of an OTC medication should take into account patient comorbidities and drug interactions  (<a class="graphic graphic_table graphicRef138544" href="/z/d/graphic/138544.html" rel="external">table 4</a>). </p><p></p><p class="bulletIndent1">As an example, selective serotonin reuptake inhibitors (SSRIs) may enhance the serotonergic effect of <a class="drug drug_general" data-topicid="8893" href="/z/d/drug information/8893.html" rel="external">dextromethorphan</a> (eg, precipitate serotonin syndrome). Although the benefits of these medications for symptom improvement in patients with acute bronchitis are uncertain, multiple clinical practice guidelines suggest that offering medications for symptom relief may help reduce requests for antibiotics [<a href="#rid1">1,50</a>]. No randomized trials have directly evaluated the use of antitussives in patients with acute bronchitis, and a large systematic review of OTC medications for acute cough, including 19 trials in over 3000 adults primarily with the common cold, concluded that there is no strong evidence for or against the effectiveness of OTC cough medications [<a href="#rid63">63</a>]. We specifically avoid use of opioid cough suppressants, such as <a class="drug drug_general" data-topicid="9291" href="/z/d/drug information/9291.html" rel="external">codeine</a>, due to their addictive potential and side effect profile.</p><p></p><p class="bulletIndent1">Antitussives for the treatment of cough are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/1428.html" rel="external">"Evaluation and treatment of subacute and chronic cough in adults"</a>.)</p><p></p><p>We suggest limiting use of inhaled beta-agonists, such as <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a>, and reserve their use for patients with wheezing and underlying pulmonary disease. A single randomized controlled trial evaluating 42 adults with acute bronchitis showed reduced rates of cough at 7 days in patients taking inhaled albuterol compared with placebo (61 versus 91 percent) [<a href="#rid64">64</a>]. About one-half of patients in this trial had wheezing at baseline. When this trial was analyzed in a meta-analysis of studies comparing other oral beta-agonists as well as other inhaled beta-agonists, similar reductions in cough were not detected [<a href="#rid65">65</a>].</p><p>We suggest not using <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a>, oral corticosteroids, or herbal remedies for cough related to acute bronchitis, either due to lack of efficacy or safety concerns. Both ibuprofen and oral corticosteroids were not shown to be more effective than placebo for reducing severity or duration of cough in randomized trials [<a href="#rid66">66,67</a>]. A systematic review found no quality randomized trials to support the use of Chinese herbs for acute bronchitis, with a note of concern about side effects and safety [<a href="#rid68">68</a>]. A liquid herbal preparation derived from the roots of <em>Pelargonium sidoides</em> (EPs 7630) appears to shorten the duration of symptoms in acute bronchitis based on two randomized trials [<a href="#rid69">69</a>]; however, these trials were determined to be low quality and concerns have been raised about potential liver injury with its use [<a href="#rid70">70,71</a>].</p><p class="headingAnchor" id="H2871710850"><span class="h3">For concurrent cold symptoms</span><span class="headingEndMark"> — </span>Many patients with acute bronchitis have associated symptoms of the common cold, particularly early in the course of illness. Analgesics, either <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> or nonsteroidal anti-inflammatory drugs (NSAIDs), may help relieve symptoms such as headache, malaise, muscle pain, and joint pain. Antihistamine/decongestant combinations, intranasal or inhaled <a class="drug drug_general" data-topicid="9300" href="/z/d/drug information/9300.html" rel="external">cromolyn</a> sodium, and intranasal <a class="drug drug_general" data-topicid="8570" href="/z/d/drug information/8570.html" rel="external">ipratropium</a> may also provide relief for some patients, though the likelihood of benefit should be weighed against potential side effects. A detailed discussion of options and their efficacy for treating the common cold is presented separately. (See  <a class="medical medical_review" href="/z/d/html/6868.html" rel="external">"The common cold in adults: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H336651053"><span class="h2">Antimicrobial therapy</span><span class="headingEndMark"> — </span>Acute bronchitis usually is caused by viruses. Inappropriate use of antibiotics for viral respiratory infections can cause adverse events and contribute to development of antibiotic resistance.</p><p>Multiple major medical societies and health care organizations, including the CDC, American College of Physicians, and the National Health Services in the United Kingdom, specifically recommend against the routine use of empiric antibiotics for the treatment of acute bronchitis [<a href="#rid1">1,50,52</a>]. Avoidance of antibiotics for the treatment of adults with acute bronchitis was also included as a component of the Healthcare Effectiveness Data and Information Set reported to the National Committee for Quality Assurance in 2007 and included as a National Quality Forum quality measure [<a href="#rid51">51,72</a>].</p><p>The rare instances in which antibiotics may improve outcomes are discussed below. (See <a class="local">'Rare indications for use'</a> below.)</p><p class="headingAnchor" id="H21"><span class="h3">Avoiding antibiotic overuse</span><span class="headingEndMark"> — </span>For the great majority of patients with acute bronchitis, we recommend not using empiric antibiotics. We suggest having an explicit discussion on the risks and benefits of antibiotic use for patients who desire antibiotics  (<a class="graphic graphic_table graphicRef142304" href="/z/d/graphic/142304.html" rel="external">table 5</a>). For most patients, the risks associated with antibiotic use outweigh the benefits. Discussion can also help align patient and provider expectations. A systematic review found that a physician's perception of patient desire for antibiotics was strongly associated with antibiotic prescription, more so than actual patient desire [<a href="#rid28">28</a>].</p><p>Multiple high-quality trials and meta-analyses have shown that antibiotics do not provide substantial benefit or enhance likelihood of cure in patients with acute bronchitis, and use can result in adverse effects [<a href="#rid1">1,53,73-76</a>]. A large observational study found no increase in the rate of complications in patients who were not prescribed antibiotics for acute lower respiratory tract infections [<a href="#rid77">77</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial evaluating over 2000 patients with acute bronchitis found no difference in symptom severity or duration in adults treated with <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a> compared with placebo [<a href="#rid74">74</a>]. Lack of antibiotic efficacy was also observed in a prespecified subgroup analysis of over 500 adults &gt;60 years old. This trial was included in a meta-analysis of 11 studies comparing antibiotic treatment with placebo in 3841 patients with acute bronchitis [<a href="#rid53">53,76</a>]. Results were inconsistent across studies included in the meta-analysis, with some suggesting marginal benefit.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antibiotic use has also been associated with an increased risk of adverse effects compared with placebo in a meta-analysis of 11 trials with 3162 patients with acute bronchitis (risk ratio 1.22, 95% CI 1.07-1.4) [<a href="#rid53">53</a>]. The most commonly reported adverse events were nausea, vomiting, diarrhea, rash, headache, and vaginitis; serious adverse events reported included anaphylaxis [<a href="#rid53">53,73</a>]. Based on the meta-analysis, the number needed to harm with antibiotics is 24.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The effect of antibiotic use on complication rates was assessed in a prospective cohort study evaluating over 28,000 adults with acute cough lasting &lt;3 weeks without radiographic evidence of pneumonia. Major complications, including hospital admission and death, occurred in &lt;1 percent of patients; no significant difference in event rates was detected when comparing patients given immediate antibiotic prescriptions with delayed prescription or no prescription [<a href="#rid77">77</a>].</p><p></p><p>Antibiotic use also alters the patient's microbiome (which may actually impair immune function) and carries the risk of inducing antibiotic-resistant organisms both in the individual patient and in the community [<a href="#rid78">78-80</a>]. Furthermore, antibiotic use also comes at increased financial cost.</p><p>Despite these data, inappropriate antibiotic prescription for the treatment of bronchitis is widespread. Studies indicate that 50 to 90 percent of patients with acute bronchitis who seek care are given antibiotics, making acute bronchitis one of the most common reasons for antibiotic overuse [<a href="#rid28">28,60,81-86</a>].</p><p>Reducing inappropriate use for the treatment of acute bronchitis is a national and international health care priority [<a href="#rid1">1,50-52</a>]. To promote appropriate antibiotic use, the CDC has launched a program that offers <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fantibiotic-use%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLDj0bcQeo1FjfZMbmc3YaEYxidDv5mrvdO%2F151SiRm6NJhJBEdXwiSY7TMzBUpGqOg%3D%3D&amp;TOPIC_ID=6870" target="_blank">online educational resources</a> for both patients and providers.</p><p class="headingAnchor" id="H2336019102"><span class="h3">Rare indications for use</span><span class="headingEndMark"> — </span>Antimicrobial therapy is generally reserved for cases in which a specific pathogen is suspected or diagnosed in patients who are at high risk for complications or when treatment might limit spread of a contagious illness. The most common scenarios are discussed below:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Influenza</strong> – Most patients with influenza do not require therapy. Treatment is reserved for hospitalized patients or those at high risk for complications  (<a class="graphic graphic_table graphicRef72029" href="/z/d/graphic/72029.html" rel="external">table 3</a>). Neuraminidase inhibitors, either <a class="drug drug_general" data-topicid="9460" href="/z/d/drug information/9460.html" rel="external">oseltamivir</a> or <a class="drug drug_general" data-topicid="10323" href="/z/d/drug information/10323.html" rel="external">zanamivir</a>, are the recommended first-line agents, though local antiviral resistance patterns should be taken into account when prescribing therapy  (<a class="graphic graphic_table graphicRef50350" href="/z/d/graphic/50350.html" rel="external">table 6</a>). Treatment is most effective when given early in the course of illness. When indicated, treatment should not be withheld while awaiting the results of diagnostic testing. (See  <a class="medical medical_review" href="/z/d/html/6998.html" rel="external">"Seasonal influenza in nonpregnant adults: Treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pertussis</strong> – Antibiotic therapy is recommended for clinically suspected or confirmed pertussis in patients with cough ≤3 weeks and suggested for pregnant women with cough &lt;6 weeks. Antibiotics can also be considered in other circumstances in which treatment may limit spread  (<a class="graphic graphic_algorithm graphicRef132607 graphicRef132606" href="/z/d/graphic/132607.html" rel="external">algorithm 2A-B</a>). Macrolides are first-line therapy  (<a class="graphic graphic_table graphicRef75339" href="/z/d/graphic/75339.html" rel="external">table 7</a> and <a class="graphic graphic_algorithm graphicRef132606" href="/z/d/graphic/132606.html" rel="external">algorithm 2B</a>). (See  <a class="medical medical_review" href="/z/d/html/8044.html" rel="external">"Pertussis infection in adolescents and adults: Treatment and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>COVID-19</strong> – Treatment of COVID-19 is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/127429.html" rel="external">"COVID-19: Management in hospitalized adults"</a> and  <a class="medical medical_review" href="/z/d/html/139068.html" rel="external">"COVID-19: Management of adults with acute illness in the outpatient setting"</a>.)</p><p></p><p>Treatment for acute bronchitis due to <em>M. pneumoniae</em> or <em>C. pneumoniae</em>, in the absence of pneumonia, is generally not recommended. Direct evidence supporting this approach is limited to a single randomized trial that showed no difference in cough in patients given <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a> compared with patients given placebo [<a href="#rid87">87</a>].</p><p>There are limited data to guide the best treatment approach for patients with the rare diagnosis of bronchitis due to <em>B. bronchiseptica</em>. Tetracyclines and fluoroquinolones have been used in most cases reported in the literature with success [<a href="#rid23">23,88</a>]. However, resistance profiles vary [<a href="#rid16">16,23</a>], and selection of antibiotic should be based on susceptibility testing results. Emergence of resistance while on therapy has also been reported in immunocompromised patients [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H522753080"><span class="h1">FOLLOW-UP</span><span class="headingEndMark"> — </span>Most patients with acute bronchitis recover without complications within 1 to 3 weeks and do not require follow-up but should be educated on features that warrant concern such as new-onset fever, difficulty breathing, symptoms lasting &gt;3 to 4 weeks, or bloody sputum.</p><p>The evaluation of patients presenting with cough lasting &gt;3 weeks is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1460.html" rel="external">"Causes and epidemiology of subacute and chronic cough in adults"</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15889.html" rel="external">"Patient education: Acute bronchitis (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16896.html" rel="external">"Patient education: Cough in adults (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/84035.html" rel="external">"Patient education: What you should know about antibiotics (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16905.html" rel="external">"Patient education: Coughing up blood (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/4004.html" rel="external">"Patient education: Acute bronchitis in adults (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> −<strong> </strong>Acute bronchitis is a common clinical condition characterized by cough, with or without sputum production. It is typically self-limited, resolving within one to three weeks. (See <a class="local">'Definitions'</a> above and <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes</strong> − The majority of cases of acute bronchitis are caused by infection with respiratory viruses, such as rhinoviruses, coronaviruses, influenza viruses, and respiratory syncytial virus  (<a class="graphic graphic_figure graphicRef139455" href="/z/d/graphic/139455.html" rel="external">figure 1</a>). Bacteria are rare causes, accounting for &lt;10 percent of cases. The most common bacterial causes are <em>Bordetella pertussis</em>,<em> Mycoplasma pneumoniae</em>,<em> </em>and<em> Chlamydia pneumoniae. </em>(See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> − Acute bronchitis should be suspected in patients with an acute onset but persistent cough (often lasting one to three weeks) who do not have clinical findings suggestive of pneumonia and who do not have chronic obstructive pulmonary disease. For most patients, the diagnosis can be made based on history and physical examination. Apart from testing for COVID-19, additional testing is typically not needed  (<a class="graphic graphic_algorithm graphicRef131527" href="/z/d/graphic/131527.html" rel="external">algorithm 1</a>). (See <a class="local">'Clinical diagnosis'</a> above and <a class="local">'Differential diagnosis'</a> above.) </p><p></p><p class="bulletIndent1">Chest radiographs are indicated when acute bronchitis cannot be clinically distinguished from pneumonia  (<a class="graphic graphic_figure graphicRef135143" href="/z/d/graphic/135143.html" rel="external">figure 2</a>). Reasonable indications for suspecting pneumonia and obtaining imaging include abnormal vital signs (pulse &gt;100/minute, respiratory rate &gt;24 breaths/minute, temperature &gt;38°C [100.4°F], or oxygen saturation &lt;95 percent), signs of consolidation on lung examination (rales, egophony, or tactile fremitus), and mental status changes in patients &gt;75 years old. (See <a class="local">'Differential diagnosis'</a> above and <a class="local">'Chest radiograph'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment focus</strong> − For most patients, acute bronchitis is self-limited; patient education and symptom control are the cornerstones of care  (<a class="graphic graphic_table graphicRef138544" href="/z/d/graphic/138544.html" rel="external">table 4</a>). We discuss the expected course of illness with each patient. Reassurance that acute bronchitis typically resolves in one to three weeks without therapy can reduce inappropriate antibiotic use and improve patient satisfaction. (See <a class="local">'Treatment'</a> above and  <a class="medical medical_basics" href="/z/d/html/15889.html" rel="external">"Patient education: Acute bronchitis (The Basics)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cough relief</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonpharmacologic</strong> − For patients with acute bronchitis who are bothered by cough, we first offer nonpharmacologic options for cough relief such as throat lozenges, hot tea, and smoking cessation or avoidance of secondhand smoke  (<a class="graphic graphic_table graphicRef138544" href="/z/d/graphic/138544.html" rel="external">table 4</a>). (See <a class="local">'For cough'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pharmacologic</strong> − For patients with acute bronchitis who desire medication for cough relief, we suggest over-the-counter medications such as <a class="drug drug_general" data-topicid="8893" href="/z/d/drug information/8893.html" rel="external">dextromethorphan</a> or <a class="drug drug_general" data-topicid="8503" href="/z/d/drug information/8503.html" rel="external">guaifenesin</a> rather than other medications  (<a class="graphic graphic_table graphicRef138544" href="/z/d/graphic/138544.html" rel="external">table 4</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We avoid opioid cough suppressants (eg, <a class="drug drug_general" data-topicid="9291" href="/z/d/drug information/9291.html" rel="external">codeine</a>) due to their addictive potential and adverse effect profile. We reserve inhaled beta-agonists, such as <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a>, for patients with wheezing and underlying pulmonary disease. (See <a class="local">'For cough'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoiding antibiotic overuse</strong> − For patients with acute bronchitis, we recommend <strong>not</strong> treating with empiric antibiotic therapy (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). Acute bronchitis is a leading cause of antibiotic overuse; reducing inappropriate antibiotic use for this indication is a global health care priority  (<a class="graphic graphic_table graphicRef142304" href="/z/d/graphic/142304.html" rel="external">table 5</a>). (See <a class="local">'Avoiding antibiotic overuse'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rare indications for antimicrobials</strong> − Antimicrobial therapy is generally reserved for cases in which a specific pathogen is suspected or diagnosed (particularly in patients who are at high risk for complications) or when treatment might limit spread of a contagious illness. Key examples include suspicion for influenza in a high-risk patient and pertussis  (<a class="graphic graphic_table graphicRef114182" href="/z/d/graphic/114182.html" rel="external">table 1</a>). (See <a class="local">'Rare indications for use'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Harris AM, Hicks LA, Qaseem A, High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 2016; 164:425.</a></li><li><a class="nounderline abstract_t">Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10 1999; :1.</a></li><li><a class="nounderline abstract_t">Wenzel RP, Fowler AA 3rd. Clinical practice. Acute bronchitis. N Engl J Med 2006; 355:2125.</a></li><li class="breakAll">Centers for Disease Control and Prevention, National Respiratory and Enteric Virus Surveillance System https://www.cdc.gov/surveillance/nrevss/hmpv/natl-trend.html (Accessed on March 16, 2017).</li><li><a class="nounderline abstract_t">Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003; 187:785.</a></li><li><a class="nounderline abstract_t">Clark TW, Medina MJ, Batham S, et al. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect 2014; 69:507.</a></li><li><a class="nounderline abstract_t">Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990; 84:377.</a></li><li><a class="nounderline abstract_t">Jonsson JS, Sigurdsson JA, Kristinsson KG, et al. Acute bronchitis in adults. How close do we come to its aetiology in general practice? Scand J Prim Health Care 1997; 15:156.</a></li><li><a class="nounderline abstract_t">Creer DD, Dilworth JP, Gillespie SH, et al. Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax 2006; 61:75.</a></li><li><a class="nounderline abstract_t">MacKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996; 11:557.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Pertussis (whooping cough):  Surveillance and reporting. https://www.cdc.gov/pertussis/surv-reporting.html (Accessed on March 13, 2017).</li><li><a class="nounderline abstract_t">Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555.</a></li><li><a class="nounderline abstract_t">Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275:1672.</a></li><li><a class="nounderline abstract_t">Wadowsky RM, Castilla EA, Laus S, et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol 2002; 40:637.</a></li><li><a class="nounderline abstract_t">Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315:161.</a></li><li><a class="nounderline abstract_t">Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243.</a></li><li><a class="nounderline abstract_t">Goldberg JD, Kamboj M, Ford R, et al. 'Kennel cough' in a patient following allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 2009; 44:381.</a></li><li><a class="nounderline abstract_t">Dworkin MS, Sullivan PS, Buskin SE, et al. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1999; 28:1095.</a></li><li><a class="nounderline abstract_t">Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326.</a></li><li><a class="nounderline abstract_t">Berkowitz DM, Bechara RI, Wolfenden LL. An unusual cause of cough and dyspnea in an immunocompromised patient. Chest 2007; 131:1599.</a></li><li><a class="nounderline abstract_t">Huebner ES, Christman B, Dummer S, et al. Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation. J Clin Microbiol 2006; 44:2581.</a></li><li><a class="nounderline abstract_t">Brady C, Ackerman P, Johnson M, McNamara J. Bordetella bronchiseptica in a pediatric Cystic Fibrosis center. J Cyst Fibros 2014; 13:43.</a></li><li><a class="nounderline abstract_t">García-de-la-Fuente C, Guzmán L, Cano ME, et al. Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica. Diagn Microbiol Infect Dis 2015; 82:20.</a></li><li><a class="nounderline abstract_t">Monti M, Diano D, Allegrini F, et al. Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection. BMC Infect Dis 2017; 17:644.</a></li><li><a class="nounderline abstract_t">Powers HR, Shah K. Bordetella bronchiseptica bloodstream infection in a renal transplant patient. Transpl Infect Dis 2017; 19.</a></li><li><a class="nounderline abstract_t">Ebell MH, Lundgren J, Youngpairoj S. How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature. Ann Fam Med 2013; 11:5.</a></li><li><a class="nounderline abstract_t">Kinkade S, Long NA. Acute Bronchitis. Am Fam Physician 2016; 94:560.</a></li><li><a class="nounderline abstract_t">McKay R, Mah A, Law MR, et al. Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections. Antimicrob Agents Chemother 2016; 60:4106.</a></li><li><a class="nounderline abstract_t">Altiner A, Wilm S, Däubener W, et al. Sputum colour for diagnosis of a bacterial infection in patients with acute cough. Scand J Prim Health Care 2009; 27:70.</a></li><li><a class="nounderline abstract_t">Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 1987; 25:251.</a></li><li><a class="nounderline abstract_t">Bushyhead JB, Wood RW, Tompkins RK, et al. The effect of chest radiographs on the management and clinical course of patients with acute cough. Med Care 1983; 21:661.</a></li><li><a class="nounderline abstract_t">Cao AM, Choy JP, Mohanakrishnan LN, et al. Chest radiographs for acute lower respiratory tract infections. Cochrane Database Syst Rev 2013; :CD009119.</a></li><li><a class="nounderline abstract_t">Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001; 134:521.</a></li><li><a class="nounderline abstract_t">Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278:1440.</a></li><li><a class="nounderline abstract_t">Singal BM, Hedges JR, Radack KL. Decision rules and clinical prediction of pneumonia: evaluation of low-yield criteria. Ann Emerg Med 1989; 18:13.</a></li><li><a class="nounderline abstract_t">Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:95S.</a></li><li><a class="nounderline abstract_t">Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157:1453.</a></li><li><a class="nounderline abstract_t">Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998; 26:811.</a></li><li><a class="nounderline abstract_t">Moore M, Stuart B, Little P, et al. Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study. Eur Respir J 2017; 50.</a></li><li><a class="nounderline abstract_t">Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278:901.</a></li><li><a class="nounderline abstract_t">Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281:1512.</a></li><li><a class="nounderline abstract_t">Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet 1995; 345:665.</a></li><li><a class="nounderline abstract_t">Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Rev Anti Infect Ther 2016; 14:633.</a></li><li><a class="nounderline abstract_t">Klausner JD, Passaro D, Rosenberg J, et al. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. J Infect Dis 1998; 177:161.</a></li><li><a class="nounderline abstract_t">Martini H, Detemmerman L, Soetens O, et al. Improving specificity of Bordetella pertussis detection using a four target real-time PCR. PLoS One 2017; 12:e0175587.</a></li><li><a class="nounderline abstract_t">Burgos-Rivera B, Lee AD, Bowden KE, et al. Evaluation of Level of Agreement in Bordetella Species Identification in Three U.S. Laboratories during a Period of Increased Pertussis. J Clin Microbiol 2015; 53:1842.</a></li><li><a class="nounderline abstract_t">Kauffmann F, Varraso R. The epidemiology of cough. Pulm Pharmacol Ther 2011; 24:289.</a></li><li><a class="nounderline abstract_t">Jónsson JS, Gíslason T, Gíslason D, Sigurdsson JA. Acute bronchitis and clinical outcome three years later: prospective cohort study. BMJ 1998; 317:1433.</a></li><li><a class="nounderline abstract_t">Hallett JS, Jacobs RL. Recurrent acute bronchitis: the association with undiagnosed bronchial asthma. Ann Allergy 1985; 55:568.</a></li><li class="breakAll">National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing https://www.nice.org.uk/guidance/ng120/resources/cough-acute-antimicrobial-prescribing-pdf-66141652166341 (Accessed on February 26, 2021).</li><li class="breakAll">National Quality Forum (NQF). Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis. Available at: http://www.qualityforum.org/MeasureDetails.aspx?actid=0&amp;SubmissionId=1216#p=5&amp;s=n&amp;so=a (Accessed on October 04, 2017).</li><li class="breakAll">Choosing Wisely Canada http://www.choosingwiselycanada.org/recommendations/emergency-medicine/ (Accessed on March 16, 2017).</li><li><a class="nounderline abstract_t">Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2014; :CD000245.</a></li><li><a class="nounderline abstract_t">Bakhit M, Del Mar C, Gibson E, Hoffmann T. Shared decision making and antibiotic benefit-harm conversations: an observational study of consultations between general practitioners and patients with acute respiratory infections. BMC Fam Pract 2018; 19:165.</a></li><li><a class="nounderline abstract_t">Johnson MC, Hulgan T, Cooke RG, et al. Operationalising outpatient antimicrobial stewardship to reduce system-wide antibiotics for acute bronchitis. BMJ Open Qual 2021; 10.</a></li><li><a class="nounderline abstract_t">Macfarlane J, Holmes W, Gard P, et al. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ 2002; 324:91.</a></li><li><a class="nounderline abstract_t">Coxeter P, Del Mar CB, McGregor L, et al. Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochrane Database Syst Rev 2015; :CD010907.</a></li><li><a class="nounderline abstract_t">de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, et al. Prescription Strategies in Acute Uncomplicated Respiratory Infections: A Randomized Clinical Trial. JAMA Intern Med 2016; 176:21.</a></li><li><a class="nounderline abstract_t">Meeker D, Linder JA, Fox CR, et al. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA 2016; 315:562.</a></li><li><a class="nounderline abstract_t">Kraus EM, Pelzl S, Szecsenyi J, Laux G. Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: An analysis of routine data. PLoS One 2017; 12:e0174584.</a></li><li><a class="nounderline abstract_t">Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev 2017; 9:CD004417.</a></li><li><a class="nounderline abstract_t">Tonkin-Crine SK, Tan PS, van Hecke O, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev 2017; 9:CD012252.</a></li><li><a class="nounderline abstract_t">Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev 2014; :CD001831.</a></li><li><a class="nounderline abstract_t">Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994; 39:437.</a></li><li><a class="nounderline abstract_t">Becker LA, Hom J, Villasis-Keever M, van der Wouden JC. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev 2015; :CD001726.</a></li><li><a class="nounderline abstract_t">Llor C, Moragas A, Bayona C, et al. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial. BMJ 2013; 347:f5762.</a></li><li><a class="nounderline abstract_t">Hay AD, Little P, Harnden A, et al. Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection: A Randomized Clinical Trial. JAMA 2017; 318:721.</a></li><li><a class="nounderline abstract_t">Jiang L, Li K, Wu T. Chinese medicinal herbs for acute bronchitis. Cochrane Database Syst Rev 2012; :CD004560.</a></li><li><a class="nounderline abstract_t">Timmer A, Günther J, Motschall E, et al. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev 2013; :CD006323.</a></li><li><a class="nounderline abstract_t">Douros A, Bronder E, Andersohn F, et al. Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study. Int J Mol Sci 2016; 17.</a></li><li><a class="nounderline abstract_t">Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond) 2013; 13:7.</a></li><li><a class="nounderline abstract_t">Barnett ML, Linder JA. Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010. JAMA 2014; 311:2020.</a></li><li><a class="nounderline abstract_t">Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA 2005; 293:3029.</a></li><li><a class="nounderline abstract_t">Little P, Stuart B, Moore M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013; 13:123.</a></li><li><a class="nounderline abstract_t">Moore M, Stuart B, Coenen S, et al. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups. Br J Gen Pract 2014; 64:e75.</a></li><li><a class="nounderline abstract_t">Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2017; 6:CD000245.</a></li><li><a class="nounderline abstract_t">Little P, Stuart B, Smith S, et al. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ 2017; 357:j2148.</a></li><li><a class="nounderline abstract_t">Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc 2014; 89:107.</a></li><li><a class="nounderline abstract_t">Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 2016; 8:39.</a></li><li><a class="nounderline abstract_t">Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014; 157:121.</a></li><li><a class="nounderline abstract_t">Ebell MH, Radke T. Antibiotic use for viral acute respiratory tract infections remains common. Am J Manag Care 2015; 21:e567.</a></li><li><a class="nounderline abstract_t">Ncube NB, Solanki GC, Kredo T, Lalloo R. Antibiotic prescription patterns of South African general medical practitioners for treatment of acute bronchitis. S Afr Med J 2017; 107:119.</a></li><li><a class="nounderline abstract_t">Silverman M, Povitz M, Sontrop JM, et al. Antibiotic Prescribing for Nonbacterial Acute Upper Respiratory Infections in Elderly Persons. Ann Intern Med 2017; 166:765.</a></li><li><a class="nounderline abstract_t">McCullough AR, Pollack AJ, Plejdrup Hansen M, et al. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust 2017; 207:65.</a></li><li><a class="nounderline abstract_t">Glinz D, Leon Reyes S, Saccilotto R, et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother 2017; 72:3205.</a></li><li><a class="nounderline abstract_t">Stenehjem E, Wallin A, Fleming-Dutra KE, et al. Antibiotic Prescribing Variability in a Large Urgent Care Network: A New Target for Outpatient Stewardship. Clin Infect Dis 2020; 70:1781.</a></li><li><a class="nounderline abstract_t">King DE, Williams WC, Bishop L, Shechter A. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract 1996; 42:601.</a></li><li><a class="nounderline abstract_t">Rampelotto RF, Hörner A, Hörner C, et al. Pneumonia caused by Bordetella bronchiseptica in two HIV-positive patients. Sao Paulo Med J 2016; 134:268.</a></li></ol></div><div id="topicVersionRevision">Topic 6870 Version 90.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26785402" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15782448" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Current estimates from the National Health Interview Survey, 1996.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17108344" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical practice. Acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17108344" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical practice. Acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12599052" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Human metapneumovirus infections in young and elderly adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25108123" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2174179" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9323784" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Acute bronchitis in adults. How close do we come to its aetiology in general practice?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16227331" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8905509" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Treatment of acute bronchitis in adults without underlying lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8905509" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Treatment of acute bronchitis in adults without underlying lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16221778" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Efficacy of an acellular pertussis vaccine among adolescents and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8637142" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prevalence and incidence of adult pertussis in an urban population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11825984" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3724806" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1889042" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Human infections associated with Bordetella bronchiseptica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19234511" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : 'Kennel cough' in a patient following allogeneic hematopoietic stem cell transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10452641" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15831828" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17494814" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : An unusual cause of cough and dyspnea in an immunocompromised patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16825386" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24011471" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Bordetella bronchiseptica in a pediatric Cystic Fibrosis center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25703895" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Microbiological and clinical aspects of respiratory infections associated with Bordetella bronchiseptica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28946850" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28865149" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Bordetella bronchiseptica bloodstream infection in a renal transplant patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23319500" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27929206" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Acute Bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27139474" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19242860" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sputum colour for diagnosis of a bacterial infection in patients with acute cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3625141" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6350743" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The effect of chest radiographs on the management and clinical course of patients with acute cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24369343" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Chest radiographs for acute lower respiratory tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11255532" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9356004" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2642673" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Decision rules and clinical prediction of pneumonia: evaluation of low-yield criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16428698" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9224224" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Influence of age on symptoms at presentation in patients with community-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9564457" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29167296" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9302241" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10227321" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7885119" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : What will it take to stop physicians from prescribing antibiotics in acute bronchitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27219826" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Antibiotic prescribing for acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9419183" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28403204" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Improving specificity of Bordetella pertussis detection using a four target real-time PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25809969" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Evaluation of Level of Agreement in Bordetella Species Identification in Three U.S. Laboratories during a Period of Increased Pertussis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21044889" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The epidemiology of cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9822398" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Acute bronchitis and clinical outcome three years later: prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3901831" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Recurrent acute bronchitis: the association with undiagnosed bronchial asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3901831" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Recurrent acute bronchitis: the association with undiagnosed bronchial asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3901831" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Recurrent acute bronchitis: the association with undiagnosed bronchial asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3901831" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Recurrent acute bronchitis: the association with undiagnosed bronchial asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24585130" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Antibiotics for acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30292242" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Shared decision making and antibiotic benefit-harm conversations: an observational study of consultations between general practitioners and patients with acute respiratory infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34210668" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Operationalising outpatient antimicrobial stewardship to reduce system-wide antibiotics for acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11786454" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26560888" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26719947" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prescription Strategies in Acute Uncomplicated Respiratory Infections: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26864410" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28350820" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: An analysis of routine data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28881007" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Delayed antibiotic prescriptions for respiratory infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28881002" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25420096" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Over-the-counter (OTC) medications for acute cough in children and adults in community settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7864949" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Albuterol delivered by metered-dose inhaler to treat acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26333656" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24097128" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28829884" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22336804" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Chinese medicinal herbs for acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24146345" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Pelargonium sidoides extract for treating acute respiratory tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26784183" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23472485" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Adverse effects of herbal medicines: an overview of systematic reviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24846041" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15972565" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23265995" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24567620" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28626858" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Antibiotics for acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28533265" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24388028" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : A clinician's primer on the role of the microbiome in human health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27074706" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24679531" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Role of the microbiota in immunity and inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26619058" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Antibiotic use for viral acute respiratory tract infections remains common.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28220736" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Antibiotic prescription patterns of South African general medical practitioners for treatment of acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28492914" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Antibiotic Prescribing for Nonbacterial Acute Upper Respiratory Infections in Elderly Persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28701117" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28961815" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31641768" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Antibiotic Prescribing Variability in a Large Urgent Care Network: A New Target for Outpatient Stewardship.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8656171" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Effectiveness of erythromycin in the treatment of acute bronchitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27191248" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Pneumonia caused by Bordetella bronchiseptica in two HIV-positive patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
